For Covid-19 Vaccine Information

Please use the contact details below:

Phone: +358981710294 (local language)

Email: jgcc_emea@its.jnj.com


Visit our COVID-19 vaccine site to access following information:

  • Patient Information Leaflet (PIL)
  • Vaccination card
  • Summary of Product Characteristics (SmPC)
  • Storage, Dosage & Administration
  • Adverse event and product quality compliant reporting

EMA raises awareness of clinical care recommendations to manage suspected thrombosis with thrombocytopenia syndrome:


Visit Janssen.com/finland to read more about Janssen Finland and our work against COVID-19.
2021-03-11 | EM-56027